SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001583648-19-000021
Filing Date
2019-05-10
Accepted
2019-05-10 16:02:41
Documents
55
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pirs3-31x201910xq.htm 10-Q 868955
2 EXHIBIT 31.1 pirs3-31x19ex311.htm EX-31.1 9916
3 EXHIBIT 31.2 pirs3-31x19ex312.htm EX-31.2 9734
4 EXHIBIT 32.1 pirs3-31x19ex321.htm EX-32.1 5800
5 EXHIBIT 32.2 pirs3-31x19ex322.htm EX-32.2 5672
  Complete submission text file 0001583648-19-000021.txt   4454804

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pirs-20190331.xml EX-101.INS 883326
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pirs-20190331.xsd EX-101.SCH 34248
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pirs-20190331_cal.xml EX-101.CAL 51103
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pirs-20190331_def.xml EX-101.DEF 178899
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pirs-20190331_lab.xml EX-101.LAB 426099
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pirs-20190331_pre.xml EX-101.PRE 257028
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 19814801
SIC: 8731 Services-Commercial Physical & Biological Research